Clin2
NCT07063667Likely a fitNot yet recruiting

AI model helps diagnose early-stage breast cancer

Breast Cancer, MetastaticArtifical Intelligence

Part of Cancer, Skin clinical trials.

This trial uses an artificial intelligence model to improve the accuracy of diagnosing early-stage breast cancer. The AI analyzes breast mass pathology results to help doctors make better decisions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
900 people
Ages
19 years to 85 years
Study type
Observational

Who can take part

  • You have been diagnosed with breast cancer or a breast mass has been ruled out as cancerous
  • You have pathology results available for a breast mass
  • You are not currently pregnant or breastfeeding
  • You do not have breast implants
  • You have not had radiation therapy or chemotherapy
  • You do not have a mental disorder that would affect participation

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06717984Recruiting
AI model for breast cancer from tissue images

This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.

Dhaka
NCT07205276Not yet recruiting
AI breast MRI study for early screening

This study uses an artificial intelligence (AI) model to analyze breast MRI images (non-contrast) to help detect breast cancer earlier. It's looking at whether the AI can find signs of cancer without needing a contrast dye injection.

NCT06517979Recruiting
AI model to detect cancer spread to lymph nodes

This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.

Guangzhou, Guangdong
NCT06649565Recruiting
AI model to predict breast cancer treatment response

This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.

Beijing, Beijing Municipality
NCT07327970Recruiting
AI test to predict breast cancer treatment response

This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.

Incheon
NCT07411443Recruiting
AI breast cancer screening study for women

This study tests whether artificial intelligence (AI) can improve breast cancer screening in women. It may help find cancer earlier and more accurately.

Shanghai, Shaghai

Hear when a new Artifical Intelligence trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.